C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2001
12/19/2001	EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement
12/19/2001	EP0720605B1 Aminocyclohexylesters and uses thereof
12/19/2001	CN1327469A Organic electroluminescent element
12/19/2001	CN1327443A Substituted anilides
12/19/2001	CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/18/2001	US6331640 Diaminopropionic acid derivatives
12/18/2001	US6331639 By reacting a 3-((alkyl, alkoxy, phenyl or heteroaryl)carbonylamino)thiophene with a ketone in the presence of an acid and reducing the reaction mixture; agricultural fungicides
12/18/2001	US6331634 Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
12/18/2001	US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors
12/18/2001	US6331542 Protease inhibitors
12/18/2001	US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/18/2001	CA2208585C Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide
12/18/2001	CA2018769C Adduct-aldehyde and its use for the preparation of a vitamin-d compound
12/13/2001	WO2001094309A1 Drug composition antagonistic to both pgd2/txa2 receptors
12/13/2001	WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001	WO2001029017A3 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF η-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD
12/13/2001	US20010051719 Novel compounds
12/13/2001	US20010051640 C7 carbamoyloxy substituted taxanes
12/13/2001	US20010051614 Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
12/13/2001	US20010051368 Methods of inhibiting the effects of amyloidogenic proteins
12/13/2001	DE10027611A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP0961774B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0851850B1 Synthesis of alpha-chloro or alpha-fluoro ketones
12/12/2001	EP0810201B1 Preventive/remedy for liver disease
12/12/2001	EP0748307B1 Skin lightening compositions
12/12/2001	EP0688213B1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity
12/12/2001	CN1326452A Triketone derivative and herbicide
12/11/2001	US6329528 Reacting alkyl benzthioimidate or its acid addition salt with furan or thiofuran acid chloride compound to product adduct-intermediate; reacting with methylhydrazine to produce 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles
12/11/2001	US6329524 Cyclic sulfone containing retroviral protease inhibitors
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia
12/11/2001	US6329373 Metalloproteinase inhibitors
12/11/2001	CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
12/06/2001	WO2001092369A1 Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method of manufacturing an electronic device
12/06/2001	WO2001092251A2 Aryloxy ester and acid compounds
12/06/2001	WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001	WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001	WO2001092211A1 Compounds exhibiting thrombopoietin-like activities
12/06/2001	WO2001092188A1 Method for labeling with tritium
12/06/2001	WO2001053287A3 Di(het)arylaminothiophene derivatives
12/06/2001	WO2001046165A3 N-heteroaryl-amides and their use as parasiticides
12/06/2001	WO2001028974A3 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof
12/06/2001	US20010049374 Amidino derivatives of quinoline and naphthalene
12/06/2001	US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/06/2001	CA2410633A1 Aryloxy ester and acid compounds
12/05/2001	EP1160246A2 Functionalized thiophene oligomers and their use as fluorescent markers
12/05/2001	EP1159961A2 Treatment of tumors with compounds having RxR retinoid receptor agonist activity
12/05/2001	EP1159279A2 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1045848B1 Process for preparation of 2-aminothiazolecarboxamide derivatives
12/05/2001	EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	EP0779886B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
12/05/2001	CN1325401A Oxime derivatives and the use thereof as latent acids
12/04/2001	USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
11/2001
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090099A1 Fatty acid synthase inhibitors
11/29/2001	WO2001089453A2 Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior
11/29/2001	WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/28/2001	EP1158321A2 Dichroic light polarizers with non-periodic arrangement of different polarizing elements
11/28/2001	EP1158320A2 Dichroic light polarizers
11/28/2001	EP1157027A1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP0912089B1 Novel n-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
11/28/2001	CN1324356A Process for preparing 3-(substituted phenyl)-5-thienyl or fully)-1,2,4-triazoles and nove. intermediates utilized therein
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001	CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001	CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/27/2001	CA2018562C Process for the enzymatic cleavage of vinyl 2-aryl-propionates
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001	WO2001087822A1 Novel phenyl-propargylether derivatives
11/22/2001	WO2001087294A1 Phosphate transport inhibitors
11/22/2001	WO2001023369A3 Process for preparing benzoic acids
11/22/2001	WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/22/2001	US20010044555 Thiol and sulfur-containing O-(meth)acrylate counpounds and use thereof
11/22/2001	US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV
11/22/2001	US20010044468 Reduced in the body to produce a benzamidine; nontoxic

1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 329